Similar to ZFN and TALEN, T-cells have been genetically edited using CRISPR to knockdown immune checkpoint inhibitor programmed cell death-1 (PD-1), which is upregulated during activation of T-cells to reduce the autoimmune reaction and aid cancer cells in evading the immune system [77]. Here, PDCD1 is linked to cancer.